Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Moynihan

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|May 13, 2009
Merck defends Vioxx in court, as publisher apologises for fake journalRay Moynihan
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 27, 2009
Doctors and drug companies: is the dangerous liaison drawing to an end?Ray Moynihan
BMJ (Clinical Research Ed.)|April 8, 2009
Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of VioxxRay Moynihan
BMJ (Clinical Research Ed.)|February 11, 2010
Major changes are proposed for definitions of female sexual dysfunctionRay Moynihan
BMJ (Clinical Research Ed.)|October 18, 2003
Cochrane at crossroads over drug company sponsorshipRay Moynihan
Nature Medicine|November 8, 2008
Straight talk with...Ray Moynihan. Interview by Genevive BjornRay Moynihan
BMJ (Clinical Research Ed.)|September 14, 2002
FDA advisers warn of more deaths if drug is relaunchedRay Moynihan
BMJ (Clinical Research Ed.)|May 31, 2003
Drug company sponsorship of education could be replaced at a fraction of its costRay Moynihan
BMJ (Clinical Research Ed.)|May 31, 2003
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: DisentanglementRay Moynihan
The Medical Journal of Australia|October 19, 2011
The downsides of antidepressantsRay Moynihan
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|May 13, 2009
Merck defends Vioxx in court, as publisher apologises for fake journalRay Moynihan
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 27, 2009
Doctors and drug companies: is the dangerous liaison drawing to an end?Ray Moynihan
BMJ (Clinical Research Ed.)|April 8, 2009
Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of VioxxRay Moynihan
BMJ (Clinical Research Ed.)|February 11, 2010
Major changes are proposed for definitions of female sexual dysfunctionRay Moynihan
BMJ (Clinical Research Ed.)|October 18, 2003
Cochrane at crossroads over drug company sponsorshipRay Moynihan
Nature Medicine|November 8, 2008
Straight talk with...Ray Moynihan. Interview by Genevive BjornRay Moynihan
BMJ (Clinical Research Ed.)|September 14, 2002
FDA advisers warn of more deaths if drug is relaunchedRay Moynihan
BMJ (Clinical Research Ed.)|May 31, 2003
Drug company sponsorship of education could be replaced at a fraction of its costRay Moynihan
BMJ (Clinical Research Ed.)|May 31, 2003
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: DisentanglementRay Moynihan
The Medical Journal of Australia|October 19, 2011
The downsides of antidepressantsRay Moynihan
Pageof 17